Search results
SERA PROGNOSTICS REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS
The Herald Journal· 3 hours agoSALT LAKE CITY, May 8, 2024 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to
Analyst Report: Myriad Genetics, Inc.
Morningstar Research via Yahoo Finance· 5 hours agoPrecise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm ...
Veracyte Core Tests Maintain Growth as Firm Prepares to Shift Resources to Newest Acquisitions
GenomeWeb News· 9 hours agoVeracyte said Tuesday that it is continuing to solidify both the evidence base and the community perception of its Decipher prostate cancer test and Afirma assay for assessment ...
Myriad Genetics (MYGN) Posts Narrower-Than-Estimate Loss in Q1
Zacks via Yahoo Finance· 7 hours agoMyriad Genetics (MYGN) first-quarter average revenue per test across its product portfolio benefited...
Q1 2024 Veracyte Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 12 hours agoLast month, a publication in JCO precision oncology showed that among patients undergoing active surveillance for prostate cancer the Decipher test is prognostic& ...
Earnings call: Veracyte sees robust growth driven by diagnostics platform By Investing.com
Investing.com· 10 hours agoThe updated National Comprehensive Cancer Network (NCCN) guidelines now include a level 1b evidence...
Skill Checkup: A Woman With a Lump in Her Breast - Page 2
Medscape· 6 days agoISH testing is crucial in accurately classifying HER2 status in patients with breast cancer, particularly following IHC staining. HER2 is a protein found on the surface of most breast cancer ...
Myriad Genetics Revenues Rise 12 Percent in Q1 2024
GenomeWeb News· 22 hours agoThe "first quarter saw early indications of market share gains in hereditary cancer and prenatal testing, and we expect this trend to accelerate as we move through the year," Myriad President ...
Exercise, new drug class recommended for management of hypertrophic cardiomyopathy
Medical Xpress· 5 hours agoThe American College of Cardiology (ACC) and the American Heart Association (AHA) have released a...
Council Post: How Predictive Analytics And Proactive Maintenance Deliver Operational Resilience
Forbes· 6 days agoTim Reed is the CEO of Lynx Software Technologies, a leading mission-critical edge software company....
